Monoclonal Mouse anti‑Hepatitis E Virus HEV / Hepatitis E Virus Antibody (clone BU‑33, aa34‑123, WB) LS‑C137380
Monoclonal Mouse anti‑Hepatitis E Virus HEV / Hepatitis E Virus Antibody (clone BU‑33, aa34‑123, WB) LS‑C137380
Antibody:
HEV / Hepatitis E Virus Mouse anti-Hepatitis E Virus Monoclonal (aa34-123) (BU-33) Antibody
Reactivity:
Hepatitis E Virus
Format:
Unconjugated, Unmodified
Overview
Antibody:
HEV / Hepatitis E Virus Mouse anti-Hepatitis E Virus Monoclonal (aa34-123) (BU-33) Antibody
Reactivity:
Hepatitis E Virus
Format:
Unconjugated, Unmodified
Specifications
Description
Hepatitis E Virus antibody LS-C137380 is an unconjugated mouse monoclonal antibody to hepatitis e virus Hepatitis E Virus (HEV) (aa34-123). Validated for ELISA and WB.
Target
HEV / Hepatitis E Virus
Reactivity
Hepatitis E Virus
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Affinity purified
Immunogen
Recombinant protein corresponding to fragment (aa 34-123) Hepatitis E virus ORF 3
Specificity
Anti-Hepatitis E virus ORF 3 recognizes recombinant protein Hepatitis E virus ORF 3.
Applications
- Western blot (1:1000)
- ELISA
Presentation
Citrate-Tris-HCl buffer, pH 7.0, 0.02% Proclin 300
Storage
Store at -20°C for up to 1 year.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Hepatitis E Virus
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Hepatitis E Virus
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Hepatitis E Virus
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Hepatitis E Virus
Applications:
Western blot
Species:
Hepatitis E Virus, Human
Applications:
Western blot, ELISA
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/21/2024